FinanceCity
HealthcareNSE · BSE

Windlas Biotech Limited

WINDLAS · ISIN INE0H5O01029

Share price

₹817 -0.33%

Market capitalisation

₹1685 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹1685 Cr

Current price

₹817

-0.33% today

52W high

₹1,098

52W low

₹697

Stock P/E

26.23

P/B ratio

3.21

02 · Per share & returns

EPS (TTM)

₹31.13

Book value

₹254

ROE

12.23%

ROA

5.55%

Dividend yield

0.71%

Beta

0.27

03 · Financials (TTM)

By the numbers

Revenue

₹904 Cr

+17.70% YoY

EBITDA

₹105 Cr

Net profit

₹66.46 Cr

-2.60% YoY

Profit margin

7.35%

Operating margin

7.25%

Total debt

₹35.24 Cr

Total cash

₹270 Cr

Debt / equity

0.06x

Current ratio

1.95x

Payout ratio

18.62%

04 · Analyst view

Target price

Upside

Consensus

NONE

Analysts

05 · Shareholding pattern

Who owns WINDLAS?

Shareholding pattern not yet captured for this company. Pulled from NSE corporate filings on the next ownership refresh.

06 · Registration & listing

On the record

Symbol
WINDLAS
Exchange
NSE · BSE
CIN
ISIN
INE0H5O01029
BSE code
543329
Sector
Healthcare
Industry
Face value
₹5
Listing date
15 Aug 2021
Employees
Headquarters
Dehradun, India

07 · About

What is Windlas Biotech Limited?

Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India. The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services. It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable and dispersible tablets, customized generics, and complex generics and multi-drug combinations, as well as injectables, including liquid vials, lyophilized vials, and ampoules. In addition, the company offers generic drugs for respiratory, anti-diabetic, gastroenterology, cardiovascular and multivitamin, neuro anti-psychotic, diabetic care, nutraceuticals, nutritional supplement, urology, pain management, and injectable therapies. It also exports generic medicines, health supplements, and custom-branded formulations. Windlas Biotech Limited was incorporated in 2001 and is headquartered in Dehradun, India.

08 · Common questions

Frequently asked

What is the CIN of Windlas Biotech Limited?+

The Corporate Identity Number for Windlas Biotech Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Windlas Biotech Limited?+

Promoter and group-holding details for Windlas Biotech Limited are disclosed quarterly via stock-exchange filings. Detailed pattern is refreshed weekly here from BSE and NSE corporate filings.

What is the market capitalisation of Windlas Biotech Limited?+

Windlas Biotech Limited (WINDLAS) has a market capitalisation of approximately ₹1685 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other healthcare listings

Full sector →